These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 33492572)

  • 61. Cancer-associated fibroblasts: Key criminals of tumor pre-metastatic niche.
    Dong G; Chen P; Xu Y; Liu T; Yin R
    Cancer Lett; 2023 Jul; 566():216234. PubMed ID: 37236390
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Revisiting macrophages in ovarian cancer microenvironment: development, function and interaction.
    El-Arabey AA; Alkhalil SS; Al-Shouli ST; Awadalla ME; Alhamdi HW; Almanaa TN; Mohamed SSEM; Abdalla M
    Med Oncol; 2023 Apr; 40(5):142. PubMed ID: 37039909
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Single-Cell RNA Sequencing in Lung Cancer: Revealing Phenotype Shaping of Stromal Cells in the Microenvironment.
    Zhang J; Song C; Tian Y; Yang X
    Front Immunol; 2021; 12():802080. PubMed ID: 35126365
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The role of tumor-associated macrophages in breast cancer progression (review).
    Obeid E; Nanda R; Fu YX; Olopade OI
    Int J Oncol; 2013 Jul; 43(1):5-12. PubMed ID: 23673510
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression.
    Cirri P; Chiarugi P
    Cancer Metastasis Rev; 2012 Jun; 31(1-2):195-208. PubMed ID: 22101652
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Fibroblast heterogeneity and its impact on extracellular matrix and immune landscape remodeling in cancer.
    Yamauchi M; Gibbons DL; Zong C; Fradette JJ; Bota-Rabassedas N; Kurie JM
    Matrix Biol; 2020 Sep; 91-92():8-18. PubMed ID: 32442601
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Fibroblasts in the Tumor Microenvironment: Shield or Spear?
    Alkasalias T; Moyano-Galceran L; Arsenian-Henriksson M; Lehti K
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29883428
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Progress on cancer associated fibroblasts in tumor immunoregulation].
    Li G; He J; Wang Q
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2018 May; 47(5):558-563. PubMed ID: 30693700
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Developing neobavaisoflavone nanoemulsion suppresses lung cancer progression by regulating tumor microenvironment.
    Ye H; He X; Feng X
    Biomed Pharmacother; 2020 Sep; 129():110369. PubMed ID: 32563983
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Crosstalk between cancer-associated fibroblasts and immune cells in cancer.
    An Y; Liu F; Chen Y; Yang Q
    J Cell Mol Med; 2020 Jan; 24(1):13-24. PubMed ID: 31642585
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance.
    Fiori ME; Di Franco S; Villanova L; Bianca P; Stassi G; De Maria R
    Mol Cancer; 2019 Mar; 18(1):70. PubMed ID: 30927908
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Loss of exosomal miR-148b from cancer-associated fibroblasts promotes endometrial cancer cell invasion and cancer metastasis.
    Li BL; Lu W; Qu JJ; Ye L; Du GQ; Wan XP
    J Cell Physiol; 2019 Mar; 234(3):2943-2953. PubMed ID: 30146796
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Invasion-Related Factors as Potential Diagnostic and Therapeutic Targets in Oral Squamous Cell Carcinoma-A Review.
    Siriwardena SBSM; Tsunematsu T; Qi G; Ishimaru N; Kudo Y
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29758011
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Tumour Microenvironment: The General Principles of Pathogenesis and Implications in Diffuse Large B Cell Lymphoma.
    Sinkarevs S; Strumfs B; Volkova S; Strumfa I
    Cells; 2024 Jun; 13(12):. PubMed ID: 38920685
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A history of exploring cancer in context.
    Maman S; Witz IP
    Nat Rev Cancer; 2018 Jun; 18(6):359-376. PubMed ID: 29700396
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Genetic regulation and potentially therapeutic application of cancer-associated fibroblasts in oral cancer.
    Wang J; Min A; Gao S; Tang Z
    J Oral Pathol Med; 2014 May; 43(5):323-34. PubMed ID: 23782231
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Alterations in the methylome of the stromal tumour microenvironment signal the presence and severity of prostate cancer.
    Lawrence MG; Pidsley R; Niranjan B; Papargiris M; Pereira BA; Richards M; Teng L; Norden S; Ryan A; Frydenberg M; Stirzaker C; Taylor RA; Risbridger GP; Clark SJ
    Clin Epigenetics; 2020 Mar; 12(1):48. PubMed ID: 32188493
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effect of FGF/FGFR pathway blocking on lung adenocarcinoma and its cancer-associated fibroblasts.
    Hegab AE; Ozaki M; Kameyama N; Gao J; Kagawa S; Yasuda H; Soejima K; Yin Y; Guzy RD; Nakamura Y; Ornitz DM; Betsuyaku T
    J Pathol; 2019 Oct; 249(2):193-205. PubMed ID: 31090071
    [TBL] [Abstract][Full Text] [Related]  

  • 79. How Macrophages Become Transcriptionally Dysregulated: A Hidden Impact of Antitumor Therapy.
    Medvedeva GF; Kuzmina DO; Nuzhina J; Shtil AA; Dukhinova MS
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800829
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Resveratrol and Tumor Microenvironment: Mechanistic Basis and Therapeutic Targets.
    Talib WH; Alsayed AR; Farhan F; Al Kury LT
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32961987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.